"Universal Cells"
Cells are the basic structures and units of an organism. Stem cells are multi-potential cells with the ability to replicate themselves. Under certain conditions, stem cells can differentiate into a variety of functional cells, with the potential function of regenerating various tissues and organs, which the medical community calls "universal cells".
This is a cutting-edge technology in the biomedical field
Now it has been
The biological research team led by Zhuji scientist Yu Junying conquered it
And entered the industrial production trial production stage
Traditional stem cells need to be obtained from human embryos, using the technology researched by Yu Junying, only by extracting ordinary people's blood, reprogramming, reversal and other technologies, IPSC (induced pluripotent stem cells) can be generated. IPSCs are equivalent to the cells in the blastocyst during embryonic development for 5-7 days, and have the ability to develop into more than 200 functional cells in the human body. Because iPSC has the characteristics of infinite proliferation and differentiation pluripotency, it has broad application prospects in the fields of cell medicine, cancer treatment, and drug screening.
(Network illustration)
In the future, with the characteristics of IPSC unlimited proliferation and differentiation pluripotency (that is, universal cells), medical problems such as leukemia and Parkinson's disease are expected to be overcome, and the existing medical means of mankind will be completely subverted.
Let's get to know this Zhuji scientist
▼▼▼
Zhuji scientist Yu Junying
Yu Junying was born in Tanxi Village, Nguyen Town. After graduating from the Department of Biology of Peking University in 1997, he entered the University of Pennsylvania to pursue a doctorate in biology. In 2003, after graduating, Dr. Yu Junying joined Thomson Laboratory as a research assistant under the famous biologist James Thomson, who successfully isolated human stem cells for the first time.
★
November 2007
Yu Junying's success in culturing human stem cells with non-cloning techniques has caused a sensation in the world.
End of 2015
After Yu Junying returned to China, he founded Zhongsheng Traceability Biotechnology Co., Ltd. in Hefei High-tech Zone, Anhui Province, and served as the chairman of the company.
In 2018
Yu Junying's research team successfully prepared the first case of Chinese group of general-purpose induced pluripotent stem cells.
At present, the medical problems that Zhongsheng is tackling include cancer and Parkinson's disease. An immune cell differentiated by IPSC is injected into the human body through infusion and injection, which can enhance immunity and then kill cancer cells. Parkinson's disease can also be cured by transplanting IPSC-differentiated dopamine neurons. In the next phase, clinical trials will be prepared.
Yu Junying also has a long-term wish, hoping that cell medicine will be affordable for ordinary people. Just as type O blood can be delivered to everyone, the cells in some super donors are special, and the IPSCs formulated with their cells can also be used for most population treatments, which can reduce the cost of existing cell medicine to 1%.
Kudos to this Zhuji scientist who leads the development of biotechnology innovation!
……